| Battling chemoresistance in cancer: root causes and strategies to uproot them A Ramos, S Sadeghi, H Tabatabaeian International journal of molecular sciences 22 (17), 9451, 2021 | 94 | 2021 |
| Oral administration of protein nanoparticles: An emerging route to disease treatment S Sadeghi, WK Lee, SN Kong, A Shetty, CL Drum Pharmacological research 158, 104685, 2020 | 51 | 2020 |
| Cooverexpression of EpCAM and c-myc genes in malignant breast tumours S Sadeghi, Z Hojati, H Tabatabaeian Journal of genetics 96, 109-118, 2017 | 48 | 2017 |
| rs11895168 C allele and the increased risk of breast cancer in Isfahan population Z Salimi, S Sadeghi, H Tabatabaeian, K Ghaedi, M Fazilati The Breast 28, 89-94, 2016 | 28 | 2016 |
| Upregulation of miR-222 in both Helicobacter pylori-infected and noninfected gastric cancer patients M Noormohammad, S Sadeghi, H Tabatabaeian, K Ghaedi, A Talebi, ... Journal of genetics 95, 991-995, 2016 | 27 | 2016 |
| ESR1 single nucleotide polymorphism rs1062577 (c.* 3804T> A) alters the susceptibility of breast cancer risk in Iranian population Z Dehghan, S Sadeghi, H Tabatabaeian, K Ghaedi, M Azadeh, M Fazilati, ... Gene 611, 9-14, 2017 | 25 | 2017 |
| Predicting the Shapes of Protein Complexes Through Collision Cross Section Measurements and Database Searches M Landreh, C Sahin, J Gault, S Sadeghi, CL Drum, povilas uzdavinys, ... | 24 | 2020 |
| The association between rs1972820 and the risk of breast cancer in Isfahan population N Zabihi, S Sadeghi, H Tabatabaeian, K Ghaedi, M Azadeh, M Fazilati Journal of cancer research and therapeutics 13 (1), 26-32, 2017 | 23 | 2017 |
| HER4 rs1595065 3'UTR variant is a possible risk factor for HER2 positivity among breast cancer patients B Moradi, H Tabatabaeian, S Sadeghi, M Azadeh, K Ghaedi Thrita 5 (4), 2016 | 17 | 2016 |
| Bioorthogonal catalysis for treatment of solid tumors using thermostable, self-assembling, single enzyme nanoparticles and natural product conversion with indole-3-acetic acid S Sadeghi, ND Masurkar, G Vallerinteavide Mavelli, S Deshpande, ... ACS nano 16 (7), 10292-10301, 2022 | 12 | 2022 |
| ErbB4 3′-UTR variant (c.* 3622A> G) is associated with ER/PR negativity and advanced breast cancer M Tabatabian, H Mesrian Tanha, H Tabatabaeian, S Sadeghi, K Ghaedi, ... Indian Journal of Clinical Biochemistry 35 (1), 115-120, 2020 | 12 | 2020 |
| A general approach to protein folding using thermostable exoshells S Sadeghi, S Deshpande, G Vallerinteavide Mavelli, A Aksoyoglu, ... Nature Communications 12 (1), 5720, 2021 | 9 | 2021 |
| Nanoencapsulation as a general solution for lyophilization of labile substrates G Vallerinteavide Mavelli, S Sadeghi, SS Vaidya, SN Kong, CL Drum Pharmaceutics 13 (11), 1790, 2021 | 6 | 2021 |
| Optimization of real time PCR for precise measurement of HER2 overexpression in breast cancer specimens S Sadeghi, H Tabatabaeian, Z Hojati Research in Molecular Medicine 3 (2), 37-44, 2015 | 6 | 2015 |
| PTBP1 correlates with HER2 positivity, lymph node spread and metastasis in breast cancer S Tabatabaeian, S Sadeghi, H Tabatabaeian Gene Reports 19, 100659, 2020 | 5 | 2020 |
| Gastrointestinal tract stabilized protein delivery using disulfide thermostable exoshell system S Sadeghi, G Vallerinteavide Mavelli, SS Vaidya, CL Drum International Journal of Molecular Sciences 23 (17), 9856, 2022 | 3 | 2022 |
| Laboratory scale production of complex protein substrates using substrate-complimentary nanoenvironments S Deshpande, S Sadeghi, GM Vallerinteavide, MA Aksoyoglu, J Bafna, ... | | 2021 |
| Volume: 4: Issue-3: March-2015 ISSN: 2278-0246 www. ijapbs. com THE MOLECULAR ROLE OF HUMAN EPIDERMAL GROWTH FACTOR 2 (HER2) IN BREAST CANCER S Sadeghi, H Tabatabaeian, Z Hojati | | |
Hossein TabatabaeianPeter MacCallum Cancer CentreVerified email at petermac.org
